title: Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
abstract: With the rapid and widespread adoption of minimally invasive procedures (laparoscopic and robotic) for the treatment of prostate and bladder cancers in the last decade, concerns have been raised regarding whether the technique can emulate the time-tested gold standard open procedures. This article briefly reviews the indications for lymph node dissection for bladder and prostate cancer, and reviews the role of extended lymphadenectomy in each procedure. Much of the focus of this review is on minimally invasive approaches and the technical aspects of the procedures, the feasibility of the robotic technique, and early oncologic outcomes.
authors: Department of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
authors: A Ari
authors: AA
authors: Hakimi
authors: Reza
authors: R
authors: Ghavamian
mesh_terms: D015653:Cystectomy / Q000379:methods / Q000401:mortality; D005240:Feasibility Studies; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods* / Q000639:trends; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008297:Male; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D009361:Neoplasm Invasiveness / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000601:surgery; D009367:Neoplasm Staging; D011379:Prognosis; D011468:Prostatectomy / Q000379:methods / Q000401:mortality; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D018570:Risk Assessment; D012371:Robotics; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*